Inhibition of tumor rejection by gammadelta T cells and IL-10

Cell Immunol. 2003 Feb;221(2):107-14. doi: 10.1016/s0008-8749(03)00066-2.

Abstract

Although many tumors express tumor-specific antigens, most fail to stimulate effective immune responses. Tumors generally lack co-stimulatory molecules, which can lead to tolerance of tumor-specific T cells and progressive tumor growth. Here, we demonstrate that the ovalbumin (OVA) transfected EL4 tumor, E.G7-OVA, grows progressively in syngeneic mice even though the tumor can be rejected if the mice are immunized with OVA in adjuvant. E.G7-OVA grew more rapidly in RAG-1 deficient than sufficient mice suggesting that normal mice make an abortive immune response to this tumor. Depletion of gammadelta T cells or IL-10 augmented the ability of B6 mice to reject E.G7-OVA. Spleen cells from normal, but not IL-10 knockout, mice reconstituted rapid tumor growth in gammadelta T cell-deficient mice. Thus, gammadelta T cells play an important role in preventing immune elimination of this tumor by a mechanism that directly or indirectly involves IL-10.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibody Formation / immunology
  • CD8-Positive T-Lymphocytes / immunology*
  • Crosses, Genetic
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Genes, RAG-1 / immunology
  • Immune Tolerance / immunology
  • Interleukin-10 / immunology*
  • Lymphoma, T-Cell / genetics
  • Lymphoma, T-Cell / immunology
  • Lymphoma, T-Cell / pathology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Ovalbumin / immunology*
  • Phagocytosis
  • Receptors, Antigen, T-Cell, gamma-delta / immunology*
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Receptors, Antigen, T-Cell, gamma-delta
  • Interleukin-10
  • Ovalbumin